Synapse - Neerav Shukla

Search Within

Neerav Shukla

Results (160)

Preliminary report of the phase 1 study of the DOT1L inhibitor, pinometostat, EPZ-5676, in children with relapsed or refractory MLL-r acute leukemia: Safety, exposure and target inhibition

Meeting Abstract

Shukla, N.; O'Brien, M. M.; Silverman, L. B.; Pauly, M.; Wetmore, C.; Loh, M. L.; Whitlock, J. A.; Brown, P.; Thomson, B.; Blakemore, S. J.; more...
Blood (2015)

Fulltext@MSK | Save

Multi-center clinical trial of CAR T cells in pediatric/young adult patients with relapsed B-cell ALL

Meeting Abstract

Curran, K. J.; Riviere, I.; Silverman, L. B.; Kobos, R.; Shukla, N.; Steinherz, P. G.; Boulad, F.; Prockop, S.; Scaradavou, A.; Margossian, S. P.; more...
Blood (2015)

Fulltext@MSK | Save

Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas

Journal Article

Gounder, M.; Desai, V.; Kuk, D.; Agaram, N.; Arcila, M.; Durham, B.; Keohan, M. L.; Dickson, M. A.; D'Angelo, S. P.; Shukla, N.; more...
European Journal of Cancer (2015)

Fulltext@MSK | Save

Ewing sarcoma: A tough road to clinically relevant biomarkers

Journal Article

Shukla, N.
Pediatric Blood and Cancer (2015)

Fulltext@MSK | Save

Clinical comprehensive genomic profiling of B-acute lymphoblastic leukemia identifies targetable kinase pathway mutations in a significant subset of cases

Meeting Abstract

Yao, J. J. ; Arcila, M.; Shukla, N.; Kobos, R.; Park, J.; Douer, D.; Wang, L.; Roshal, M.; Maslak, P.; Levine, R.; more...
Laboratory Investigation (2015)

Fulltext@MSK | Save

Clinical comprehensive genomic profiling of B-acute lymphoblastic leukemia identifies targetable kinase pathway mutations in a significant subset of cases

Meeting Abstract

Yao, J. J. ; Arcila, M.; Shukla, N.; Kobos, R.; Park, J.; Douer, D.; Wang, L.; Roshal, M.; Maslak, P.; Levine, R.; more...
Modern Pathology (2015)

Fulltext@MSK | Save

High disease-free survival (DFS) supports continued investigation of double-unit cord blood transplantation (DCBT) in children with high-risk acute leukemia especially in the setting of single units with low dose and/or a high degree of HLA-mismatch

Meeting Abstract

Scaradavou, A.; Lubin, M.; Hilden, P.; Boulad, F.; Curran, K. J.; Kobos, R.; Prockop, S. E.; O'Reilly, R. J.; Tonon, J. A.; Byam, C.; more...
Biology of Blood and Marrow Transplantation (2015)

Fulltext@MSK | Save

PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study

Journal Article

Moskowitz, A. J.; Schöder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
Lancet Oncology (2015)

Fulltext@MSK | Save

Myeloablative double-unit cord blood transplantation (CBT) in pediatric patients with high-risk acute leukemia demonstrates encouraging disease-free survival with both TBI and chemotherapy-only-based conditioning

Meeting Abstract

Scaradavou, A.; Lubin, M. N.; Hilden, P.; Boulad, F.; Curran, K. J.; Kobos, R.; Prockop, S. E.; O'Reilly, R. J.; Tonon, J. A.; Byam, C.; more...
Blood (2014)

Fulltext@MSK | Save

Greater total dose and duration of treatment with bortezomib are associated with higher incidence of chalazion and other ocular side effects

Meeting Abstract

Ganesh, K.; Batlevi, C.; Zhang, Z. G.; Hassoun, H.; Lendvai, N.; Landau, H.; Moskowitz, C. H.; Caron, P.; Motzer, R.; Giralt, S. A.; more...
Blood (2014)

Fulltext@MSK | Save